RankingsPricing
  1. US-listed companies
  2. AGIOS PHARMACEUTICALS, INC.
  3. Raw

AGIOS PHARMACEUTICALS, INC.AGIO

Market cap
$1.5B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash and cash equivalents72147216110371811272031398876
Marketable securities95328245381--484445817644689817
Accounts receivable, net-----5921-234
Inventory-----1715-81928
Prepaid expenses and other current assets359101717242440393540
Total current assets1703603375604456146126371,064833834966
Marketable securities------1539826631429638
Operating lease assets------948575655443
Property and equipment, net4623252424313229231512
Other non-current assets011210-13445
Total assets2014924206196148588918531,4381,2399371,663
Accounts payable41115172318222717191017
Accrued expenses71416323442536032304347
Income taxes payable-----------1
Operating lease liabilities------7711141517
Total current liabilities376153889594939460636881
Operating Lease, Liability, Noncurrent------1069786725740
Other non-current liabilities---------311
Total liabilities----239171250453146138126122
Common Stock, Value, Outstanding---------000
Additional paid-in capital2455916308421,1751,7942,1562,2432,3342,3862,4372,494
Accumulated other comprehensive loss0-0-0-0-1-200-1-13-0-2
Accumulated deficit-113-167-285-483-798-1,105-1,516-1,843-239-471-823-149
Treasury stock, at cost (16,216,411 shares at December 31, 2024 and December 31, 2023)--------802802802802
Total stockholders’ equity1314243453593766886414001,2921,1018111,541
Total liabilities and stockholders’ equity2014924206196148588918531,4381,2399371,663